Emerging Therapies for Hepatitis C

The combination of pegylated interferon (PEG-IFN) and ribavirin (RBV), the current therapy for hepatitis C virus (HCV) infection, has saved the lives of many HCV-infected patients. Direct-acting antivirals (DAAs) target several sites of HCV nonstructural proteins, resulting in the cessation of viral...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Do Young, Ahn, Sang Hoon, Han, Kwang-Hyub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Gut and Liver 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164256/
https://www.ncbi.nlm.nih.gov/pubmed/25228970
http://dx.doi.org/10.5009/gnl14083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164256/
https://www.ncbi.nlm.nih.gov/pubmed/25228970
http://dx.doi.org/10.5009/gnl14083

Ejemplares similares